Syros Pharmaceuticals, Inc.
SYRSDelisted Mar 10, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001556263
Syros Pharmaceuticals, Inc. was delisted on Mar 10, 2025; its insiders filed their last Form 4 on Dec 4, 2024; 44 institutions reported holding it in 13F filings for Q4 2024, worth $1.20M in total; no superinvestor held it.
Q2 2025 vs. Q1 2025
How the institutions holding Syros Pharmaceuticals, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 7 | 0 | −7 |
| Shares | 483.2K | 0 | −483.2K (−100.0%) |
| Value | $12.4K | $0 | −$12.4K (−100.0%) |
New holders (0)
Institutions that held Syros Pharmaceuticals, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
None.
Sold out (7)
Institutions that held Syros Pharmaceuticals, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Acadian Asset Management LLC | 329,793 | $9.00K |
| Baader Bank INC | 83,864 | $1.91K |
| 1492 Capital Management LLC | 39,244 | $1.18K |
| XTX Topco Ltd | 10,053 | $290 |
| Simplex Trading, LLC | 4,123 | $0 |
| Steward Partners Investment Advisory, LLC | 8 | $0 |
| FNY Investment Advisers, LLC | 16,100 | $0 |